Your browser doesn't support javascript.
loading
Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Liu, Jun-Ning; Li, Ji-Jiang; Yan, Shu; Zhang, Guang-Nian; Yi, Peng-Sheng.
Affiliation
  • Liu JN; Department of Hepato-Biliary-Pancreas II, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Li JJ; Department of Hepato-Biliary-Pancreas II, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Yan S; Department of Hepato-Biliary-Pancreas II, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Zhang GN; Department of Hepato-Biliary-Pancreas II, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Yi PS; Department of Hepato-Biliary-Pancreas II, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Front Oncol ; 13: 1233247, 2023.
Article in En | MEDLINE | ID: mdl-37427117
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland